Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
1.28
- 0.04 (-3.02%)
2:29 PM ET on Sep 19, 2017
Delayed at least 20 minutes.
Day High 1.35
Day Low 1.27
52-Week High 27.36
Volume 243,595
Print Friendly